The University of Chicago Header Logo

Connection

Eric Polley to Female

This is a "connection" page, showing publications Eric Polley has written about Female.
Connection Strength

0.621
  1. Identifying treatment heterogeneity in atrial fibrillation using a novel causal machine learning method. Am Heart J. 2023 06; 260:124-140.
    View in: PubMed
    Score: 0.044
  2. Systemic treatment and radiotherapy, breast cancer subtypes, and survival after long-term clinical follow-up. Breast Cancer Res Treat. 2019 Jun; 175(2):287-295.
    View in: PubMed
    Score: 0.033
  3. Functional analysis and clinical classification of 462 germline BRCA2 missense variants affecting the DNA binding domain. Am J Hum Genet. 2024 Mar 07; 111(3):584-593.
    View in: PubMed
    Score: 0.012
  4. Electronic Health Records (EHRs) Can Identify Patients at High Risk of Fracture but Require Substantial Race Adjustments to Currently Available Fracture Risk Calculators. J Gen Intern Med. 2023 Dec; 38(16):3451-3459.
    View in: PubMed
    Score: 0.011
  5. Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C. Cancer Res. 2023 08 01; 83(15):2557-2571.
    View in: PubMed
    Score: 0.011
  6. Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival. Cancer Med. 2023 08; 12(15):16142-16162.
    View in: PubMed
    Score: 0.011
  7. Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2. J Clin Oncol. 2023 03 20; 41(9):1703-1713.
    View in: PubMed
    Score: 0.011
  8. Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay. Clin Cancer Res. 2022 09 01; 28(17):3742-3751.
    View in: PubMed
    Score: 0.011
  9. Ultrasound high-definition microvasculature imaging with novel quantitative biomarkers improves breast cancer detection accuracy. Eur Radiol. 2022 Nov; 32(11):7448-7462.
    View in: PubMed
    Score: 0.010
  10. Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis. JAMA Oncol. 2022 04 01; 8(4):587-596.
    View in: PubMed
    Score: 0.010
  11. Quantitative Biomarkers for Cancer Detection Using Contrast-Free Ultrasound High-Definition Microvessel Imaging: Fractal Dimension, Murray's Deviation, Bifurcation Angle & Spatial Vascularity Pattern. IEEE Trans Med Imaging. 2021 12; 40(12):3891-3900.
    View in: PubMed
    Score: 0.010
  12. Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast. J Clin Oncol. 2021 12 10; 39(35):3918-3926.
    View in: PubMed
    Score: 0.010
  13. Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer. J Natl Cancer Inst. 2021 10 01; 113(10):1429-1433.
    View in: PubMed
    Score: 0.010
  14. Risk of Late-Onset Breast Cancer in Genetically Predisposed Women. J Clin Oncol. 2021 11 01; 39(31):3430-3440.
    View in: PubMed
    Score: 0.010
  15. Comparison of the Prevalence of Pathogenic Variants in Cancer Susceptibility Genes in Black Women and Non-Hispanic White Women With Breast Cancer in the United States. JAMA Oncol. 2021 Jul 01; 7(7):1045-1050.
    View in: PubMed
    Score: 0.010
  16. Preserved skeletal muscle oxidative capacity in older adults despite decreased cardiorespiratory fitness with ageing. J Physiol. 2021 07; 599(14):3581-3592.
    View in: PubMed
    Score: 0.010
  17. Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk Score. J Clin Oncol. 2021 08 10; 39(23):2564-2573.
    View in: PubMed
    Score: 0.010
  18. A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech. Nat Commun. 2021 06 08; 12(1):3452.
    View in: PubMed
    Score: 0.010
  19. Adipose tissue macrophage populations and inflammation are associated with systemic inflammation and insulin resistance in obesity. Am J Physiol Endocrinol Metab. 2021 07 01; 321(1):E105-E121.
    View in: PubMed
    Score: 0.010
  20. Prediction of Invasive Breast Cancer Using Mass Characteristic Frequency and Elasticity in Correlation with Prognostic Histologic Features and Immunohistochemical Biomarkers. Ultrasound Med Biol. 2021 08; 47(8):2193-2201.
    View in: PubMed
    Score: 0.010
  21. Early assessment of shear wave elastography parameters foresees the response to neoadjuvant chemotherapy in patients with invasive breast cancer. Breast Cancer Res. 2021 04 29; 23(1):52.
    View in: PubMed
    Score: 0.010
  22. Differential Contribution of ASPECTS Regions to Clinical Outcome after Thrombectomy for Acute Ischemic Stroke. AJNR Am J Neuroradiol. 2021 06; 42(6):1104-1108.
    View in: PubMed
    Score: 0.010
  23. Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on Prognosis. J Clin Oncol. 2021 05 20; 39(15):1619-1630.
    View in: PubMed
    Score: 0.010
  24. Two-stage deep learning model for fully automated pancreas segmentation on computed tomography: Comparison with intra-reader and inter-reader reliability at full and reduced radiation dose on an external dataset. Med Phys. 2021 May; 48(5):2468-2481.
    View in: PubMed
    Score: 0.010
  25. Association between clot composition and stroke origin in mechanical thrombectomy patients: analysis of the Stroke Thromboembolism Registry of Imaging and Pathology. J Neurointerv Surg. 2021 Jul; 13(7):594-598.
    View in: PubMed
    Score: 0.010
  26. Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk. J Natl Cancer Inst. 2021 03 01; 113(3):329-337.
    View in: PubMed
    Score: 0.010
  27. Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significance. Am J Hum Genet. 2021 03 04; 108(3):458-468.
    View in: PubMed
    Score: 0.010
  28. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nat Commun. 2021 02 17; 12(1):1078.
    View in: PubMed
    Score: 0.010
  29. A Population-Based Study of Genes Previously Implicated in Breast Cancer. N Engl J Med. 2021 02 04; 384(5):440-451.
    View in: PubMed
    Score: 0.010
  30. Molecular Profiling-Based Assignment of Cancer Therapy (NCI-MPACT): A Randomized Multicenter Phase II Trial. JCO Precis Oncol. 2021; 5.
    View in: PubMed
    Score: 0.010
  31. Does Body Position Affect Ultrasound Measurements of Bladder-Wall Elasticity? Ultrasound Med Biol. 2021 04; 47(4):1115-1119.
    View in: PubMed
    Score: 0.010
  32. The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort. J Natl Cancer Inst. 2020 12 14; 112(12):1231-1241.
    View in: PubMed
    Score: 0.009
  33. Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women. J Natl Cancer Inst. 2020 12 14; 112(12):1213-1221.
    View in: PubMed
    Score: 0.009
  34. Individualized-thresholding Shear Wave Elastography combined with clinical factors improves specificity in discriminating breast masses. Breast. 2020 Dec; 54:248-255.
    View in: PubMed
    Score: 0.009
  35. Effect of Germline Mutations in Homologous Recombination Repair Genes on Overall Survival of Patients with Pancreatic Adenocarcinoma. Clin Cancer Res. 2020 12 15; 26(24):6505-6512.
    View in: PubMed
    Score: 0.009
  36. Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer. J Clin Oncol. 2020 05 01; 38(13):1409-1418.
    View in: PubMed
    Score: 0.009
  37. Predictive value of comb-push ultrasound shear elastography for the differentiation of reactive and metastatic axillary lymph nodes: A preliminary investigation. PLoS One. 2020; 15(1):e0226994.
    View in: PubMed
    Score: 0.009
  38. Classification of variants of uncertain significance in BRCA1 and BRCA2 using personal and family history of cancer from individuals in a large hereditary cancer multigene panel testing cohort. Genet Med. 2020 04; 22(4):701-708.
    View in: PubMed
    Score: 0.009
  39. Assessment of MRI-detected lesions on screening tomosynthesis in patients with newly diagnosed breast cancer. Clin Imaging. 2020 Jan; 59(1):50-55.
    View in: PubMed
    Score: 0.009
  40. HIV elite control is associated with reduced TRAILshort expression. AIDS. 2019 09 01; 33(11):1757-1763.
    View in: PubMed
    Score: 0.009
  41. A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients. Genet Med. 2020 02; 22(2):407-415.
    View in: PubMed
    Score: 0.009
  42. Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk. Breast Cancer Res. 2019 05 22; 21(1):68.
    View in: PubMed
    Score: 0.008
  43. Gene expression differences between matched pairs of ovarian cancer patient tumors and patient-derived xenografts. Sci Rep. 2019 04 19; 9(1):6314.
    View in: PubMed
    Score: 0.008
  44. Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands' Susceptibility Gene Mutation Status. J Natl Cancer Inst. 2019 03 01; 111(3):264-271.
    View in: PubMed
    Score: 0.008
  45. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. Am J Hum Genet. 2019 01 03; 104(1):21-34.
    View in: PubMed
    Score: 0.008
  46. Cancer susceptibility gene mutations in type I and II endometrial cancer. Gynecol Oncol. 2019 01; 152(1):20-25.
    View in: PubMed
    Score: 0.008
  47. Interaction between the microbiome and TP53 in human lung cancer. Genome Biol. 2018 08 24; 19(1):123.
    View in: PubMed
    Score: 0.008
  48. Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing. J Natl Cancer Inst. 2018 08 01; 110(8):855-862.
    View in: PubMed
    Score: 0.008
  49. Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer. JAMA. 2018 06 19; 319(23):2401-2409.
    View in: PubMed
    Score: 0.008
  50. Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models. Genet Med. 2019 01; 21(1):71-80.
    View in: PubMed
    Score: 0.008
  51. Emollient use alters skin barrier and microbes in infants at risk for developing atopic dermatitis. PLoS One. 2018; 13(2):e0192443.
    View in: PubMed
    Score: 0.008
  52. Characterizing Potentially Preventable Admissions: A Mixed Methods Study of Rates, Associated Factors, Outcomes, and Physician Decision-Making. J Gen Intern Med. 2018 05; 33(5):737-744.
    View in: PubMed
    Score: 0.008
  53. Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls. Gynecol Oncol. 2017 11; 147(2):375-380.
    View in: PubMed
    Score: 0.008
  54. Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer. JAMA Oncol. 2017 Sep 01; 3(9):1190-1196.
    View in: PubMed
    Score: 0.008
  55. Clinical Activity of the ?-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis). J Clin Oncol. 2017 May 10; 35(14):1561-1569.
    View in: PubMed
    Score: 0.007
  56. Association of ?H2AX at Diagnosis with Chemotherapy Outcome in Patients with Breast Cancer. Theranostics. 2017; 7(4):945-951.
    View in: PubMed
    Score: 0.007
  57. Diverse Human Skin Fungal Communities in Children Converge in Adulthood. J Invest Dermatol. 2016 12; 136(12):2356-2363.
    View in: PubMed
    Score: 0.007
  58. New insights on PI3K/AKT pathway alterations and clinical outcomes in breast cancer. Cancer Treat Rev. 2016 Apr; 45:87-96.
    View in: PubMed
    Score: 0.007
  59. Phase I study of the heat shock protein 90 (Hsp90) inhibitor onalespib (AT13387) administered on a daily for 2 consecutive days per week dosing schedule in patients with advanced solid tumors. Invest New Drugs. 2015 Aug; 33(4):921-30.
    View in: PubMed
    Score: 0.006
  60. Free HIV antiretroviral therapy enhances adherence among individuals on stable treatment: implications for potential shortfalls in free antiretroviral therapy. PLoS One. 2013; 8(9):e70375.
    View in: PubMed
    Score: 0.006
  61. Cediranib for metastatic alveolar soft part sarcoma. J Clin Oncol. 2013 Jun 20; 31(18):2296-302.
    View in: PubMed
    Score: 0.006
  62. Exploring large weight deletion and the ability to balance confounders when using inverse probability of treatment weighting in the presence of rare treatment decisions. Pharmacoepidemiol Drug Saf. 2013 Feb; 22(2):111-21.
    View in: PubMed
    Score: 0.005
  63. AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanoma. Proc Natl Acad Sci U S A. 2011 Apr 19; 108(16):6597-602.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.